
Defying death: The future of forever
Episode 3
Gene and stem cell therapies have been touted as the next phase in the longevity movement, with promises to rejuvenate the body at the cellular level and reverse the effects of ageing. But, as the prospect of life extension moves into the mainstream, it presents big questions for society as a whole. Are we ready for a world where people live much longer lives? In this final episode, the FT’s Michael Peel and Hannah Kuchler dive into the tough moral questions at the heart of the longevity movement. Hannah speaks to the team at Fountain Life, a longevity clinic trying to bring stem cell therapy to the middle classes. We meet Daniel Ives, founder of gene therapy company Shift Bioscience, and Liz Parrish, who has self-experimented with gene therapies through her company, Biovia. Finally, Michael speaks to Arthur Caplan, the head of the ethics board of longevity fund, Hevolution. Free to read: From immortal jellyfish to elephants: scientists probe secrets of long-lived animals Inside the billion-dollar quest to live beyond 100 Gene editing breakthrough promises to boost fight against disease This series of Tech Tonic is hosted by Michael Peel and Hannah Kuchler. It is produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio.
Publisher
FT Tech Tonic
Link
www.ft.com/tech-tonic
Published
December 10, 2025
Duration
31 min
Format
Podcast
Category
News · Daily News
Source
RSS feed
Host
Financial Times
FT Tech Tonic
@fttechtonic
#defyingdeath #future #forever
